Hardik Desai Family Trust acquires 5,412 shares in Trident Texofab

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Hardik Desai Family Trust acquired 5,412 equity shares in the open market
  • Promoter group stake increased from 6.95% to 6.99%
  • Transaction date recorded as September 21, 2026
  • Total equity capital remained unchanged at ₹14,99,57,640
powered bylight_fuzz_icon
51769420

*this image is generated using AI for illustrative purposes only.

Trident Texofab Limited saw a minor increase in promoter group holding following an open market acquisition by the Hardik Desai Family Trust. The trust purchased 5,412 equity shares on September 21, 2026, raising its stake to 6.99% of the company's total voting capital.

The disclosure was filed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, by Hardik Jigishkumar Desai, acting as trustee for the family trust. The transaction was executed through the open market route, with no encumbrances or convertible securities involved in the acquisition.

Pre and Post Acquisition Holdings

The acquisition increased the total number of shares held by the promoter group entity from 10,42,334 to 10,47,746. This represents a marginal shift in ownership percentage from 6.95% to 6.99%.

Metric Before Acquisition After Acquisition Change
Shares Held 10,42,334 10,47,746 +5,412
% of Total Voting Capital 6.95% 6.99% +0.04%

Transaction Details

The target company's equity share capital remained unchanged at ₹14,99,57,640, comprising 1,49,95,764 equity shares of ₹10 each. The diluted share capital also remained constant at this level, indicating no outstanding convertible instruments were affected by this trade.

  • Acquirer: Hardik Desai Family Trust (Promoter Group)
  • Mode of Acquisition: Open Market
  • Date of Acquisition: September 21, 2026
  • Number of Shares Acquired: 5,412
  • Listing Exchange: BSE

What the Numbers Show

The acquisition represents a negligible change in the overall shareholding pattern, with a 0.04% increase in the promoter group's stake. The consistency between the pre-acquisition and post-acquisition total diluted capital confirms that the transaction was purely secondary market activity involving existing equity shares, without any dilution from new issuances or conversions.

Historical Stock Returns for Trident Texofab

1 Day5 Days1 Month6 Months1 Year5 Years
-0.57%-3.98%-7.98%-55.31%-93.17%-43.09%

Will the Hardik Desai Family Trust continue to accumulate shares to cross the 7% SEBI disclosure threshold?

How might this incremental promoter buying influence retail investor sentiment and stock liquidity for Trident Texofab?

Are there upcoming regulatory filings or board meetings that could reveal further strategic intentions behind the promoter group's accumulation?

Trident Texofab schedules AGM for September 30 to approve FY26 results

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Trident Texofab scheduled its 18th AGM for September 30, 2026, to approve FY26 results
  • Remote e-voting opens on September 27 and closes on September 29, 2026
  • Board recommends reappointment of director Manish Halwawala who retires by rotation
  • Shareholders to approve related party transactions up to ₹25 crore with group entities
powered bylight_fuzz_icon
50331104

*this image is generated using AI for illustrative purposes only.

Trident Texofab approved its financial results for FY26 and scheduled its 18th annual general meeting during a board session on September 7, 2026. The company confirmed that the AGM will take place on September 30, 2026, at 4:00 pm via video conferencing or other audio-visual means.

The register of members and share transfer books will remain closed from September 24 to September 30, 2026, inclusive. The cut-off date for remote e-voting is set for September 23, 2026. The remote e-voting period commences on Sunday, September 27, 2026 at 9:00 am and ends on Tuesday, September 29, 2026 at 5:00 pm.

Key Board Resolutions

The board recommended the reappointment of Mr. Manish Dhirajlal Halwawala, who retires by rotation. His appointment is subject to shareholder approval at the upcoming AGM. The board also appointed CS Mebul Amareliya as the scrutinizer for the e-voting process.

The AGM agenda includes special business items such as approving related party transactions for FY27 with entities including Trident Lifeline Limited and Trident Mediquip Limited, up to a maximum aggregate value of ₹25 crore each. Additionally, shareholders are asked to approve the payment of managerial remuneration in excess of limits prescribed under the Companies Act, 2013, for directors Hardik Jigishkumar Desai, Chetan Chandrakant Jariwala, and Manish Dhirajlal Halwawala.

Cost Auditor Appointment

On the recommendation of the Audit Committee, the board appointed M/s. PAAA & Associates as the cost auditor for FY27. The firm holds registration number 006283 and will conduct the audit of cost records in accordance with Section 148 of the Companies Act, 2013. The remuneration for this appointment is set at ₹35,000 plus applicable taxes.

Particular Details
Auditor Name M/s. PAAA & Associates
Appointment Date September 7, 2026
Term Financial Year 2026-2027
Relationship Disclosure NIL

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE071Y01013/aa98e2ca-4035-40e4-a318-f03544abb608.pdf

Historical Stock Returns for Trident Texofab

1 Day5 Days1 Month6 Months1 Year5 Years
-0.57%-3.98%-7.98%-55.31%-93.17%-43.09%

How might the approval of related party transactions totaling up to ₹50 crore with Trident Lifeline and Trident Mediquip impact Trident Texofab's operational costs or profit margins in FY27?

What are the specific performance metrics or strategic initiatives that justify the proposed managerial remuneration exceeding statutory limits for the three named directors?

Will the reappointment of Mr. Manish Dhirajlal Halwala signal continuity in current management strategy, or are investors expecting new leadership directions post-AGM?

More News on Trident Texofab

1 Year Returns:-93.17%